[go: up one dir, main page]

WO2006005219A8 - A pharmaceutical composition for treating depression and the process for preparing the same - Google Patents

A pharmaceutical composition for treating depression and the process for preparing the same

Info

Publication number
WO2006005219A8
WO2006005219A8 PCT/CN2004/000551 CN2004000551W WO2006005219A8 WO 2006005219 A8 WO2006005219 A8 WO 2006005219A8 CN 2004000551 W CN2004000551 W CN 2004000551W WO 2006005219 A8 WO2006005219 A8 WO 2006005219A8
Authority
WO
WIPO (PCT)
Prior art keywords
preparing
pharmaceutical composition
same
treating depression
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2004/000551
Other languages
French (fr)
Chinese (zh)
Other versions
WO2006005219A1 (en
Inventor
Lixin Guo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ltd CHENGDU KANGHONG TECHNOLOGY ENTERPRISES (GROUP) CO
Ltd CHENGDU KANGHONG TECHNOLOG
Original Assignee
Ltd CHENGDU KANGHONG TECHNOLOGY ENTERPRISES (GROUP) CO
Ltd CHENGDU KANGHONG TECHNOLOG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd CHENGDU KANGHONG TECHNOLOGY ENTERPRISES (GROUP) CO, Ltd CHENGDU KANGHONG TECHNOLOG filed Critical Ltd CHENGDU KANGHONG TECHNOLOGY ENTERPRISES (GROUP) CO
Priority to PCT/CN2004/000551 priority Critical patent/WO2006005219A1/en
Publication of WO2006005219A1 publication Critical patent/WO2006005219A1/en
Publication of WO2006005219A8 publication Critical patent/WO2006005219A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a pharmaceutical composition for treating depression, which is prepared from forsythia fruit and acanthopanax bark. Meanwhile, a process for preparing the same is provided, mainly including steps of extracting forsythia fruit with alcohol and extracting acanthopanax bark with water, and producing the extracts into capsule or other solid dosage form.
PCT/CN2004/000551 2004-05-27 2004-05-27 A pharmaceutical composition for treating depression and the process for preparing the same Ceased WO2006005219A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/000551 WO2006005219A1 (en) 2004-05-27 2004-05-27 A pharmaceutical composition for treating depression and the process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/000551 WO2006005219A1 (en) 2004-05-27 2004-05-27 A pharmaceutical composition for treating depression and the process for preparing the same

Publications (2)

Publication Number Publication Date
WO2006005219A1 WO2006005219A1 (en) 2006-01-19
WO2006005219A8 true WO2006005219A8 (en) 2006-04-20

Family

ID=35783488

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/000551 Ceased WO2006005219A1 (en) 2004-05-27 2004-05-27 A pharmaceutical composition for treating depression and the process for preparing the same

Country Status (1)

Country Link
WO (1) WO2006005219A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112641100A (en) * 2020-11-24 2021-04-13 北京斯利安药业有限公司 Anti-depression electuary containing folic acid
CN112494520B (en) * 2021-01-07 2022-09-27 广西壮族自治区中医药研究院 Application of gecko or extract thereof in preparing anti-depression drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1169536C (en) * 2001-04-16 2004-10-06 成都康弘科技实业（集团）有限公司 Capsule for treating depression

Also Published As

Publication number Publication date
WO2006005219A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
Nguyen et al. Evaluation of antioxidant, anti-cholinesterase, and anti-inflammatory effects of culinary mushroom Pleurotus pulmonarius
WO2007109802A3 (en) Extracts and methods comprising green tea species
DE60206474D1 (en) PROCESS FOR THE PRODUCTION OF A MATRINE-CONTAINING PLANT EXTRACT
WO2007109804A3 (en) Extracts and methods comprising cinnamon species
WO2005067489A3 (en) Type ii diabetes
WO2008090410A3 (en) Cinnamomi and poria composition and uses thereof
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2009077188A8 (en) Tea composition and process for the manufacture thereof
WO2009080778A3 (en) Preparations with rosehip extracts, and method of producing rosehip extracts
EP2110135A3 (en) A pharmaceutical composition for treating depression and method for preparation thereof
WO2004075816A3 (en) Method for the production of flavonoid-containing compositions and use thereof
WO2008037707A3 (en) Valerian extract preparation
EP1972337A3 (en) Excipient and an improved method for manufacturing extracted, evaporated, granulated botanical herb product
WO2007056133A3 (en) Herbal composition for weight management
NZ601904A (en) Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts
WO2006078699A3 (en) Oral care compositions derived from the labiatae family
EP2003988A4 (en) Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea
WO2006005219A8 (en) A pharmaceutical composition for treating depression and the process for preparing the same
WO2003030822A3 (en) Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
WO2011065699A3 (en) Method for extracting a traditional herbal medicine component using a polished-rice steaming method
UA87114C2 (en) Process for preparation of extraction of ivy leaves, extraction, use thereof and drug
WO2010130393A3 (en) Orodispersible tablet containing a vardenafil salt
WO2006016383A3 (en) Natural composition
WO2006012779A8 (en) Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
WO2006099914A8 (en) Method for producing naringenin derivatives from xanthohumol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (71) THE NAME SHOULD READ "CHENGDU KANGHONG TECHNOLOGY ENTERPRISES (GROUP) CO., LTD." IN CHINESE CORRECT ;

NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase